Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials

AIMS/INTRODUCTION: This meta‐analysis aimed to evaluate the efficacy and safety/tolerability of imeglimin, a novel oral antihyperglycemic agent, administered as monotherapy and adjunctive therapy in patients with type 2 diabetes mellitus. MATERIALS AND METHODS: Parallel‐group randomized controlled t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagi, Katsuhiko, Nitta, Masahiro, Watada, Hirotaka, Kaku, Kohei, Ueki, Kohjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583642/
https://www.ncbi.nlm.nih.gov/pubmed/37610062
http://dx.doi.org/10.1111/jdi.14070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583642/
https://www.ncbi.nlm.nih.gov/pubmed/37610062
http://dx.doi.org/10.1111/jdi.14070

Ejemplares similares